Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

Open in Screener

PFE

Pfizer Inc

Jan 21 • 04:00PM ET

25.89

+0.37 1.45 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO IVV SPY VTV XLV VYM VHT DVY FDL

Index	S&P 500	P/E	15.09	EPS (ttm)	1.72	Insider Own	0.09%	Shs Outstand	5.69B	Perf Week	2.94%
Market Cap	147.20B	Forward P/E	8.70	EPS next Y	2.97	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	3.39%
Enterprise Value	194.23B	PEG	-	EPS next Q	0.58	Inst Own	66.85%	Short Float	2.29%	Perf Quarter	4.86%
Income	9.80B	P/S	2.34	EPS this Y	0.23%	Inst Trans	-0.50%	Short Ratio	2.02	Perf Half Y	2.98%
Sales	62.78B	P/B	1.59	EPS next Y	-4.58%	ROA	4.58%	Short Interest	130.02M	Perf YTD	3.98%
Book/sh	16.32	P/C	9.82	EPS next 5Y	-2.81%	ROE	10.59%	52W High	27.69 -6.50%	Perf Year	-1.56%
Cash/sh	2.64	P/FCF	14.19	EPS past 3/5Y	-28.69% -13.27%	ROIC	6.52%	52W Low	20.92 23.79%	Perf 3Y	-45.89%
Dividend Est.	1.71 (6.60%)	EV/EBITDA	7.43	Sales past 3/5Y	-7.84% 9.10%	Gross Margin	69.12%	Volatility	2.05% 1.73%	Perf 5Y	-29.76%
Dividend TTM	1.72 (6.64%)	EV/Sales	3.09	EPS Y/Y TTM	128.96%	Oper. Margin	30.99%	ATR (14)	0.50	Perf 10Y	-11.87%
Dividend Ex-Date	Jan 23, 2026	Quick Ratio	0.97	Sales Y/Y TTM	4.44%	Profit Margin	15.60%	RSI (14)	58.42	Recom	2.39
Dividend Gr. 3/5Y	2.49% 2.97%	Current Ratio	1.28	EPS Q/Q	-20.96%	SMA20	2.36%	Beta	0.43	Target Price	28.51
Payout	120.11%	Debt/Eq	0.66	Sales Q/Q	-5.92%	SMA50	2.12%	Rel Volume	0.73	Prev Close	25.52
Employees	81000	LT Debt/Eq	0.62	Earnings	Feb 03 BMO	SMA200	5.74%	Avg Volume	64.30M	Price	25.89
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	37.53% 0.94%	Trades		Volume	47,264,124	Change	1.45%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-07-26	Resumed	UBS	Neutral	$25
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51

Show Previous Ratings

Today 06:50AM	Is Pfizer an Absurdly Cheap Dividend Stock, or Just a Value Trap? (Motley Fool)
01:03AM	Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality (Reuters)
12:01AM	Johnson & Johnson Crushes Patent, Pricing Probs (The Daily Upside)
Jan-21-26 05:45PM	Pfizer (PFE) Outperforms Broader Market: What You Need to Know (Zacks)
10:06AM	Novavax Grants License for Use of Matrix-M Adjuvant to Pfizer (Zacks)
09:39AM	Loading…
09:39AM	Albert Bourla on the State of Pharma (WSJ)
08:26AM	Pfizer CEO on His Relationship With RFK Jr. (WSJ)
07:25AM	Pfizer and Novavax ink $530m vaccine delivery licensing deal (Pharmaceutical Technology)
06:46AM	3 No-Brainer Dividend Stocks to Buy Right Now -- Including Pfizer (Motley Fool)
04:06AM	Trump at Davos, Intel Earnings, Supreme Court: What to Watch This Week (The Wall Street Journal)
Jan-20-26 04:57PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:43PM	Pfizer CEO Albert Bourla: U.S. drug prices are coming down (CNBC TV)
03:58PM	Valneva Steps Back From US Approval Bid For Chikungunya Vaccine (Benzinga)
01:41PM	BMY vs GSK: Which Biopharma Giant Has Better Prospects for Now? (Zacks)
12:53PM	Novavax Pops on Pfizer Licensing Deal (GuruFocus.com)
12:14PM	Loading…
12:14PM	Shionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up (Pharmaceutical Technology)
10:42AM	Novavax Shares Rise After Licensing Deal With Pfizer (Benzinga)
10:41AM	Novavax Licenses Rights to Key Vaccine Component to Pfizer (The Wall Street Journal)
09:38AM	CorMedix vs. Mirum Pharma: Which Rare-Disease Stock is the Better Buy? (Zacks)
08:08AM	Which Pharma Stock Stands Taller Right Now: LLY or PFE? (Zacks)
05:54AM	GSK To Acquire RAPT Therapeutics In $2.2 Billion Bet On Food Allergy Breakthrough (Benzinga)
02:54AM	Texas, N. Carolina, Ohio, Pennsylvania where pharma manufacturing investments have surged (Pharma Voice)
Jan-19-26 03:44PM	Down 55%, Should You Buy the Dip on Pfizer? (Motley Fool)
03:23PM	Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All (MarketBeat)
09:31AM	Congresswoman Violates STOCK Act With Over 200 Late Trade Disclosures: Purchases Include Mag7, Healthcare Stocks (Benzinga)
09:01AM	What to Expect From Pfizer's Non-Oncology Business in Q4? (Zacks)
Jan-18-26 07:00AM	US drugmakers threaten to withhold products from Europe over prices (Financial Times)
05:04AM	Investing $10,000 in Each of These 5 Ultra-High-Yield Dividend Stocks Could Generate Over $3,700 in Passive Income in 2026 (Motley Fool)
Jan-17-26 09:13AM	The Best Dividend Stocks to Buy in 2026 and Hold Forever -- Including Pfizer (PFE) and United Parcel Service (UPS) (Motley Fool)
Jan-16-26 12:46PM	Pfizer (PFE) CEO Isn't Ready For A Fight With RFK Jr., Says Jim Cramer (Insider Monkey)
06:41AM	Loading…
06:41AM	Congresswoman Violates STOCK Act With Over 200 Late Trade Disclosures: Purchases Include Mag7, Healthcare Stocks (Benzinga)
02:00AM	Stocks With Juicy Dividends Are Tempting. But How Risky Are They? (Barrons.com)
Jan-15-26 11:40AM	Why Pfizer Inc. (PFE) is One of the Best Affordable Stocks Under $30 (Insider Monkey)
08:38AM	Will DefenCath Continue to Aid CorMedix's Top Line in Q4 Earnings? (Zacks)
12:44AM	3SBio Sees More Business Development Deals (Bloomberg)
Jan-14-26 05:45PM	Pfizer (PFE) Ascends While Market Falls: Some Facts to Note (Zacks)
08:52AM	Is It Time to Dump Your Shares of Eli Lilly? (Motley Fool)
07:59AM	JPM26: BioNTech gears up for multiproduct oncology status by 2030 (Pharmaceutical Technology)
07:45AM	PFE Market Cap Falls More Than $7B in a Month: How to Play the Stock (Zacks)
04:04AM	BioNTech Pivots Back to Oncology at JPM Conference, Teases 15 Phase III Readouts and $17B Cash Plan (MarketBeat)
Jan-13-26 09:04PM	Amneal Pharmaceuticals Eyes 2026 Growth at JPMorgan, Crexont Sales Seen Doubling in 2025 (MarketBeat)
07:25PM	JPM26: Madrigal seeks early dominance in MASH through strategic acquisitions (Pharmaceutical Technology)
02:50PM	JPM26: Pfizers Metsera deal supercharges its obesity strategy (Pharmaceutical Technology)
01:00PM	Pfizer CEO Says Company Is Pushing for FDA Priority Review Voucher (GuruFocus.com)
12:35PM	ABBV Inks Drug Pricing Deal With Trump, Joins PD-1xVEGF Bandwagon (Zacks)
08:43AM	Will AbbVie's Oncology Segment Support Top-line Growth in Q4 Earnings? (Zacks)
07:54AM	Inside Pfizer's Oncology Performance Ahead of Q4 Results (Zacks)
06:53AM	Health Care Roundup: Market Talk (The Wall Street Journal)
05:24AM	AbbVie Strikes a $100 Billion Deal With Trump. How the Drugmaker Will Dodge Tariffs. (Barrons.com)
Jan-12-26 09:06PM	Adaptive Biotechnologies Touts clonoSEQ MRD Growth, Targets Companywide Profitability in 2026 (MarketBeat)
06:42PM	Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra (Reuters)
05:45PM	3 retail trends to watch in 2026, according to NRF 2026 (Yahoo Finance Video)
05:04PM	Health Care Roundup: Market Talk (The Wall Street Journal)
05:00PM	UBS Likes Pfizer's MTSR Obesity Deal but Stays Neutral on PFE (Insider Monkey)
04:21PM	Expect a Busy Year in Obesity Drugs as New Pills Hit the Market (Barrons.com)
04:18PM	JPM Preannouncements: Why Alnylam And Sarepta Lost, But Day One Won (Investor's Business Daily)
01:35PM	Why Tempus AI Stock Jumped on Monday? (GuruFocus.com)
01:08PM	Tempus AI's Pharma Momentum Accelerates (GuruFocus.com)
12:18PM	JPM26: US biotechs Sputnik moment, Pfizers obesity ambitions and Bristol Myers big year (BioPharma Dive)
11:58AM	Pfizer Cancer Combo Drug Shows Strong Tumor Shrinkage in Colorectal Cancer Trial (Benzinga)
11:38AM	'Biotech Super Bowl' Lands With a Thud. Stocks Slide on Lack of Deal News. (Barrons.com)
11:27AM	Why Moderna Stock Is Dropping After Good News (Barrons.com)
11:20AM	MDGL Secures Exclusive Global Right for MASH Treatment From PFE (Zacks)
10:56AM	JPM Preannouncements Take Their Toll As Alnylam Slides, Tempus, Day One Pop (Investor's Business Daily)
06:24AM	AbbVie buys into PD-1/VEGF sweepstakes; Alnylam and Vertex set expectations (BioPharma Dive)
05:47AM	Tempus AI Stock Soars After Posting Triple-Digit Diagnostics Growth (Benzinga)
Jan-11-26 11:03AM	This ETF Is Proof That the Healthcare Rebound Is Real (MarketBeat)
Jan-10-26 10:00AM	Pfizers BRAFTOVI Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer (Business Wire)
Jan-09-26 01:30PM	Unusual Options Activity in Pfizer: 2 Strategies Traders Are Jumping On (Barchart)
11:19AM	Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 (Reuters)
09:50AM	Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026 (Motley Fool)
09:16AM	BMY Rallies 17.3% in Six Months: Buy, Sell or Hold the Stock? (Zacks)
07:23AM	J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts (Pharmaceutical Technology)
01:52AM	Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal - Stock Soars Overnight (Benzinga)
Jan-08-26 07:51PM	Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn (Financial Times)
04:30PM	Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026 (Business Wire)
11:59AM	Pfizer Turns To AI Where Drug Risk Is Highest (GuruFocus.com)
11:53AM	Pfizer Partners with Boltz to Use AI in Drug Discovery (GuruFocus.com)
11:46AM	Want Over $2,000 in Dividends Each Year? Invest $12,000 Each Into These 3 Stocks (Motley Fool)
09:35AM	Is LLY's Ventyx Deal Another Attempt at Diversification Beyond GLP-1? (Zacks)
09:13AM	Pfizer, Astellas Report Positive Phase 3 Trial Results for PADCEV Combination in Bladder Cancer Treatment (Insider Monkey)
08:41AM	Fed Governor Wants Huge Rate Cuts This Year: 5 High-Yield Dividend Stocks to Buy Today (24/7 Wall St.)
08:00AM	Biotech Stocks' Dark Winter Is Over. What That Means For Investors. (Investor's Business Daily)
04:10AM	Pfizer's Stock Just Dropped 6%. Can the Pharmaceutical Giant Bounce Back in 2026? (Motley Fool)
Jan-07-26 04:20PM	3 Drug Stocks to Buy at a Discount (Motley Fool)
02:16PM	Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio (Business Wire)
01:35PM	This Could Be Key to Pfizer's Turnaround in 2026 (Motley Fool)
08:33AM	Amgen Buys Dark Blue Therapeutics to Strengthen Oncology Pipeline (Zacks)
Jan-06-26 08:50PM	Warning: This Skyrocketing Stock Has a Hidden Risk (Motley Fool)
11:07AM	iShares Select Dividend Fund Has A Surprisingly High Yield For Retirees (24/7 Wall St.)
09:00AM	Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
06:43AM	Pfizer's Quarterly Earnings Preview: What You Need to Know (Barchart)
05:30AM	Big Pharma Has More Going for It Than Obesity Drugs (The Wall Street Journal)
04:11AM	5 of the Safest Ultra-High-Yield Dividend Stocks You Can Confidently Buy for 2026 (Motley Fool)
12:53AM	Motley Fool Money: Stock Market Naughty and Nice List (Motley Fool)
Jan-05-26 10:00PM	Pfizer (PFE) Plans Price Increases on About 80 Medicines Despite Broader Pricing Deals (Insider Monkey)
02:38PM	Flu Season's Here-This Dividend-Payer Controls the Shot Market (MarketBeat)
12:05PM	This Flying-Under-the-Radar Pharma Stock Pays Nearly 7% (While Everyone's Sleeping) (Motley Fool)
10:35AM	These 3 Stocks Trade at Discounts the Market Won't Ignore Forever (MarketBeat)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Business Wire)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM

Open in Screener

KMX

Carmax Inc

Jan 21 • 04:00PM ET

48.75

+1.30 2.74 %

Consumer Cyclical • Auto & Truck Dealerships • USA • NYSE

Peers: AN LAD PAG SAH ABG GPI TSLA GM F HOG

| Held by: IJR VTI VB IJS VBR SPSM VXF SLYV RWJ AVUV

Index	-	P/E	16.12	EPS (ttm)	3.02	Insider Own	0.55%	Shs Outstand	143.06M	Perf Week	4.95%
Market Cap	6.91B	Forward P/E	19.69	EPS next Y	2.48	Insider Trans	1.67%	Shs Float	141.01M	Perf Month	23.92%
Enterprise Value	24.18B	PEG	-	EPS next Q	0.18	Inst Own	104.65%	Short Float	11.09%	Perf Quarter	13.29%
Income	457.84M	P/S	0.25	EPS this Y	-17.47%	Inst Trans	-5.56%	Short Ratio	2.95	Perf Half Y	-23.26%
Sales	27.83B	P/B	1.15	EPS next Y	-6.55%	ROA	1.73%	Short Interest	15.63M	Perf YTD	26.16%
Book/sh	42.39	P/C	8.95	EPS next 5Y	-	ROE	7.46%	52W High	89.47 -45.51%	Perf Year	-38.24%
Cash/sh	5.45	P/FCF	3.54	EPS past 3/5Y	-22.80% -9.64%	ROIC	1.97%	52W Low	30.26 61.10%	Perf 3Y	-25.00%
Dividend Est.	-	EV/EBITDA	23.18	Sales past 3/5Y	-5.28% 5.66%	Gross Margin	11.31%	Volatility	3.54% 3.74%	Perf 5Y	-53.79%
Dividend TTM	-	EV/Sales	0.87	EPS Y/Y TTM	2.78%	Oper. Margin	2.50%	ATR (14)	1.71	Perf 10Y	2.29%
Dividend Ex-Date	-	Quick Ratio	0.51	Sales Y/Y TTM	0.12%	Profit Margin	1.65%	RSI (14)	73.46	Recom	3.14
Dividend Gr. 3/5Y	- -	Current Ratio	1.99	EPS Q/Q	-47.21%	SMA20	13.75%	Beta	1.33	Target Price	33.83
Payout	0.00%	Debt/Eq	2.98	Sales Q/Q	-6.73%	SMA50	23.37%	Rel Volume	0.55	Prev Close	47.45
Employees	30048	LT Debt/Eq	2.84	Earnings	Dec 18 BMO	SMA200	-10.53%	Avg Volume	5.30M	Price	48.75
IPO	Feb 04, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	40.34% 2.71%	Trades		Volume	2,911,998	Change	2.74%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-12-25	Initiated	Barclays	Underweight	$28
Nov-10-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$35
Nov-07-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-07-25	Downgrade	Needham	Buy → Hold
Nov-06-25	Downgrade	William Blair	Outperform → Mkt Perform
Nov-06-25	Downgrade	The Benchmark Company	Buy → Hold
Nov-06-25	Downgrade	JP Morgan	Neutral → Underweight	$30
Oct-07-25	Downgrade	Stephens	Overweight → Equal-Weight	$42
Sep-29-25	Downgrade	Seaport Research Partners	Buy → Neutral
Sep-26-25	Downgrade	Oppenheimer	Outperform → Perform
Sep-26-25	Downgrade	Evercore ISI	Outperform → In-line	$52
Sep-25-25	Downgrade	Wedbush	Outperform → Neutral
Aug-06-25	Upgrade	JP Morgan	Underweight → Neutral	$58
Jul-17-25	Initiated	The Benchmark Company	Buy	$75
Jul-01-25	Resumed	Morgan Stanley	Overweight	$80
May-19-25	Resumed	Wedbush	Outperform	$90
Mar-26-25	Upgrade	Stephens	Equal-Weight → Overweight	$86 → $90
Feb-06-25	Upgrade	Evercore ISI	In-line → Outperform	$90 → $110
Dec-05-24	Initiated	Stephens	Equal-Weight	$86
Mar-20-24	Upgrade	Needham	Hold → Buy	$99

Show Previous Ratings

Jan-14-26 07:50AM	CarGurus Pivots Beyond Marketplace at Needham Conference, Ramping AI and Dealer Software Push (MarketBeat)
Jan-13-26 11:05PM	3 Reasons KMX is Risky and 1 Stock to Buy Instead (StockStory)
Jan-12-26 11:43AM	Why CarMax Stock Slipped 53% In 2025 (Motley Fool)
Jan-07-26 05:59AM	CarMax promises price relief for used-car customers (Wards Auto) +5.35%
Dec-31-25 09:51AM	Here's Why You Should Offload CarMax Stock From Your Portfolio (Zacks)
09:16AM	Loading…
Dec-26-25 09:16AM	Can Carvana Stock Extend Its Strong 2025 Rally Into 2026? (Zacks)
Dec-25-25 12:31AM	The 5 Most Interesting Analyst Questions From CarMax's Q4 Earnings Call (StockStory)
Dec-22-25 08:59AM	Bear of the Day: CarMax (KMX) (Zacks)
03:34AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Dec-20-25 10:00AM	3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500 (MarketBeat)
Dec-19-25 07:38AM	CarMax Q3 Earnings Surpass Expectations, Revenues Decline Y/Y (Zacks)
12:30AM	KMX Q4 Deep Dive: Margin Reset and Leadership Transition Dominate CarMax's Strategy (StockStory)
Dec-18-25 04:18PM	Stocks to Watch Thursday: Trump Media, Micron, Lululemon, Accenture (The Wall Street Journal)
04:01PM	CarMax Inc (KMX) Q3 2026 Earnings Call Highlights: Navigating Sales Decline and Strategic ... (GuruFocus.com)
12:57PM	CarMax Cutting Prices to Draw Car Shoppers Back (The Wall Street Journal)
12:36PM	Loading…
12:36PM	CarMax Crashes into a Sales Slump as Amazon Circles the Used-Car Lot (GuruFocus.com)
11:53AM	These Stocks Are Moving the Most Today: Micron, DJT, Accenture, Tilray, Lululemon, Medline, Rivian, and More (Barrons.com)
10:49AM	CarMax Scores an Earnings Beat. The Stock Barely Moves. (Barrons.com)
10:46AM	Stock Market Today: Indexes Rise; Nvidia, Tesla Rally But Some Electronics Firms Struggle (Live Coverage) (Investor's Business Daily)
10:15AM	Stock Market Today: Dow, Small Caps Rise On Surprise Inflation Data; Nvidia, Tesla Rally (Live Coverage) (Investor's Business Daily)
09:37AM	Stock Market Today: Dow Rises On Surprise Inflation Data; Nvidia, Tesla Rally (Live Coverage) (Investor's Business Daily)
09:30AM	CarMax (KMX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:00AM	CarMax (KMX) Q3 Earnings and Revenues Top Estimates (Zacks)
07:40AM	CarMax flags lower margins, higher marketing spend; shares slide (Investing.com)
07:18AM	CarMax Beats Earnings Expectations. Why the Stock Is Falling. (Barrons.com)
07:16AM	CarMax Profit Sinks as Struggles Continue (The Wall Street Journal)
07:13AM	CarMax (NYSE:KMX) Beats Q4 CY2025 Sales Expectations (StockStory)
07:00AM	CarMax: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:50AM	CarMax Reports Third Quarter Fiscal Year 2026 Results (Business Wire)
05:33AM	Nike headlines Thursday's earnings slate (MarketWatch)
04:24AM	Loading…
04:24AM	Stock Market Today: S&P 500 and Dow strive to break 4-day losing streak, Nasdaq called higher as Micron results lift tech sentiment; CPI inflation data due; Nike earnings on tap. (MarketWatch)
03:26AM	FedEx, Nike Earnings; Inflation Report: Still to Come This Week (The Wall Street Journal)
Dec-17-25 07:00PM	November CPI, Nike earnings, mortgage rates: What to Watch (Yahoo Finance Video)
Dec-16-25 10:34PM	Spotting Winners: CarMax (NYSE:KMX) And Vehicle Retailer Stocks In Q3 (StockStory)
10:01PM	CarMax Earnings: What To Look For From KMX (StockStory)
Dec-15-25 12:48PM	Reddit Investors Have No Faith in Used Car Stocks \| CVNA CARS CARG (24/7 Wall St.)
11:20AM	Tesla Owner Regrets Thinking His EV Was An 'Investment'Says He's 'Genuinely Shocked At How Much These Things Are Tanking' After Losing $750 A Month (Benzinga)
09:15AM	Stay Ahead of the Game With CarMax (KMX) Q3 Earnings: Wall Street's Insights on Key Metrics (Zacks)
Dec-14-25 07:31AM	Trump's Fed pick comes into focus, economic data backlog clears: What to watch this week (Yahoo Finance)
05:00AM	What to Expect in Markets This Week: Jobs Report, Inflation Data, Earnings From Micron, Nike and FedEx (Investopedia)
Dec-11-25 12:29PM	Carvana Stock Is Joining the S&P 500. Should You Buy Shares Now? (Barchart)
10:00AM	Earnings Preview: CarMax (KMX) Q3 Earnings Expected to Decline (Zacks)
09:15AM	Vera Bradley (VRA) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
08:38AM	The Week Ahead: Nike, Micron Put a Bow on 2025 Earnings (Schaeffer's Research)
07:50AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Dec-09-25 11:59AM	CarMax (KMX) Sued Over Alleged "Temporary Demand Pull-Forward" and Loan Portfolio Risk- Hagens Berman (PR Newswire)
09:00AM	CarMax, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - KMX (PR Newswire)
08:05AM	AutoZone (AZO) Q1 Earnings and Revenues Miss Estimates (Zacks)
Dec-08-25 02:39PM	Carvana Stock Heads for a New High. There's More to the Story Than S&P 500 Inclusion. (Barrons.com)
12:16PM	Carvana Stock Heads for Record Closing High. There's More to Story Than S&P 500 Inclusion. (Barrons.com)
11:30AM	Carvana stock surges on S&P 500 inclusion, marking dramatic turnaround (Yahoo Finance)
08:31AM	Here's What Affected CarMax (KMX) in Q3 (Insider Monkey)
03:15AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Dec-05-25 08:56AM	Wedbush Says Its Time to Take Advantage and Buy the Dip in This 1 Former Meme Stock (Barchart)
Dec-04-25 08:00AM	The Week Ahead: Nike, Micron Put a Bow on 2025 Earnings (Schaeffer's Research)
Dec-03-25 02:56PM	CarMax (KMX) Sued Over Alleged "Temporary Demand Pull-Forward" and Loan Portfolio Risk- Hagens Berman (PR Newswire)
Dec-02-25 01:16PM	The Real Price of Passive: Its Not the Expense Ratio (etf.com)
Dec-01-25 03:18PM	KMX SHAREHOLDERS: CarMax, Inc. Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by January 2 (Newsfile)
Nov-30-25 02:15AM	What Every CarMax Investor Should Know Before Buying (Motley Fool)
Nov-29-25 10:48AM	Has KMX Stock Been Good for Investors? (Motley Fool)
Nov-28-25 05:55PM	CarMax, Inc. (KMX) Investor Lawsuit Filed, Shares Fall Again Amid Disclosure of Expected Comparable Store Unit Sales Decline -- Hagens Berman (PR Newswire)
07:48AM	Is CarMax (KMX) Facing Cyclical Weakness? (Insider Monkey)
Nov-25-25 05:00PM	Carmax Announces Third Quarter Conference Call (Business Wire) +5.33%
08:45AM	Investors in CarMax, Inc. Should Contact Levi & Korsinsky Before January 2, 2026 to Discuss Your Rights - KMX (PR Newswire)
Nov-24-25 02:54PM	Carvana Stock Is Rising. Ignore the Struggling Car Market, Say Analysts. (Barrons.com)
01:27PM	Is Carvana the 'New Used Car King?' These Analysts Think So, and the Stock Is Rising. (Investopedia)
12:30PM	Wedbush Lifts Carvana With $400 Target And 30% Upside (GuruFocus.com)
12:06PM	Carvana Stock Jumps. Ignore the Struggling Car Market, Say Analysts. (Barrons.com)
11:14AM	The Auto Market Is in Rough Shape. Buy Carvana Stock Anyway, Analyst Says. (Barrons.com)
02:41AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Nov-21-25 05:50PM	CarMax and Lithia Stocks Trade Up, What You Need To Know (StockStory) +5.40%
Nov-20-25 10:35AM	CarMax Opens First Arkansas Store in Rogers, Expanding to 42 States Nationwide (GlobeNewswire)
Nov-18-25 02:15PM	Why CarMax (KMX) Stock Is Up Today (StockStory)
09:00AM	CarMax Rolls Out Nationwide At-Home Pickup- Sell Your Car Without Leaving Your Driveway (GlobeNewswire)
Nov-17-25 11:34PM	3 Profitable Stocks We Steer Clear Of (StockStory) -6.74%
04:34PM	Amazon, Ford Partner on Used Cars. 4 Stocks That Could Be Impacted. (Barrons.com)
09:41AM	Carvana and CarMax stock falls after Ford partners with Amazon (Investing.com)
09:37AM	Ford Taps Amazon to Let Shoppers Buy Its Used Cars Online (Bloomberg)
09:00AM	Paige Bueckers and Donovan Mitchell Take the Wheel in CarMax's "Wanna Drive?" Campaign (GlobeNewswire)
Nov-16-25 10:03AM	Poorly Run CarMax (KMX) "Misjudged" The Market, Says Jim Cramer (Insider Monkey)
12:12AM	Jim Cramer on CarMax: "I Would Not Own That Stock" (Insider Monkey)
Nov-13-25 08:43PM	Lightning Round: ServiceNow's fundamentals are very good, says Jim Cramer (CNBC TV)
Nov-12-25 12:12PM	Is Carvana (CVNA) Actually In Trouble? (24/7 Wall St.)
09:45AM	Carvana initiated, AT upgraded: Wall Street's top analyst calls (The Fly)
02:49AM	CarMax Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
Nov-11-25 12:26PM	Why CarMax (KMX) Stock Is Trading Up Today (StockStory)
12:11PM	CarMax is 'stuck in neutral.' And yes, it's also about Carvana. (MarketWatch)
09:40AM	Shareholders of CarMax, Inc. (KMX): Protect Your Rights Before January 2, 2026 - Contact Levi & Korsinsky (Newsfile)
09:18AM	Shareholders who lost money in shares of CarMax, Inc. (NASDAQ: KMX) Should Contact Wolf Haldenstein Immediately (PR Newswire)
08:45AM	CarMax, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before January 2, 2026 to Discuss Your Rights - KMX (PR Newswire)
04:13AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Nov-10-25 11:34AM	CarMax downgraded by Morgan Stanley amid execution woes and leadership uncertainty (Investing.com)
09:39AM	Coinbase upgraded, Six Flags downgraded: Wall Street's top analyst calls (The Fly)
09:11AM	Here Are Mondays Top Wall Street Analyst Research Calls: Advanced Micro Devices, Alphabet, Apple, Eli Lilly, CarMax, HubSpot, and More (24/7 Wall St.)
Nov-07-25 09:33AM	Datadog, Trade Desk upgraded: Wall Street's top analyst calls (The Fly)
Nov-06-25 11:55PM	CarMax rings alarm on used car market, drags Carvana down (TheStreet) -24.33%
07:46PM	Here Are Fridays Top Wall Street Analyst Research Calls: Advanced Micro Devices, Baidu, Datadog, Expedia, Unity Software and More (24/7 Wall St.)
04:26PM	These Stocks Moved the Most Today: Duolingo, Marvell, Tesla, Qualcomm, Robinhood, CarMax, Datadog, DoorDash, and More (Barrons.com)
04:25PM	How major US stock indexes fared Thursday, 11/6/2025 (Associated Press Finance)
04:11PM	CarMax CEO abruptly steps down, Peloton recalls 800K+ bikes (Yahoo Finance Video)

CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ONeil Mark F	Director	Oct 02 '25	Buy	46.21	10,816	499,807	24,690	Oct 06 04:11 PM
STEENROD MITCHELL D	Director	Oct 02 '25	Buy	45.57	2,000	91,140	38,330	Oct 03 04:09 PM
Daniels Jon G	EVP, CAF	Jul 02 '25	Sale	70.64	1,540	108,786	2,779	Jul 03 04:11 PM
JON DANIELS	Officer	Jul 02 '25	Proposed Sale	70.64	1,540	108,790		Jul 02 04:27 PM
STEENROD MITCHELL D	Director	Apr 24 '25	Buy	65.49	1,300	85,137	33,577	Apr 25 04:08 PM
Tuite Tyler	SVP & Chief Product Officer	Jan 28 '25	Option Exercise	78.61	4,869	382,752	5,096	Jan 30 04:15 PM
Tuite Tyler	SVP & Chief Product Officer	Jan 28 '25	Sale	84.58	4,869	411,820	227	Jan 30 04:15 PM
Tuite Tyler	Officer	Jan 28 '25	Proposed Sale	84.58	4,869	411,809		Jan 28 05:11 PM

PFE

Pfizer Inc

KMX

Carmax Inc

Upgrade your FINVIZ experience